Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease

Hepatology

Volumn 23, Issue 5, 1996, Pages 1154-1158

  Suou, Takeaki ^a   Yamada, Sadako ^a   Hosho, Keiko ^a   Yoshikawa, Noritaka ^b   Kawasaki, Hironaka ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Nippon DPC Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; COLLAGEN METABOLISM; FEMALE; HUMAN; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 0029984460     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008621148     Document Type: Article

References (24)

1. Seyer JM, Hutchenson ET, Rang AH. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 1977;59:241-248.
2. Rojkind M, Giambrone MA, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979;76:710-719.
3. Hahn E, Wick G, Pencev D, Timple R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut 1980;21:63-71.
4. Niemelä O, Risteli L, Sotaniemi EA, Risteli J. Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest 1985;15:132-137.
5. Knittel T, Schuppan D, Meyer zum Buschenfeld K-H, Ramadori G. Differential expression of collagen types I, III, and IV by fatstoring (Ito) cells in vitro. Gastroenterology 1992;102:1724-1735.
6. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H. In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. HEPATOLOGY 1989;10:84-92.
7. Clement B, Emonard H, Rissel M, Druguest M, Grimaud J-A, Herbage D, Bourel M, et al. Cellular origin of collagen and fibronectin in the liver. Cell Mol Biol 1984;30:489-496.
8. Kalebic T, Carbisa S, Glaser B, Liotta LA. Basement membrane collagen: degradation by migrating endothelial cells. Science 1983;221:281-283.
9. Timpl R, Wiedemann H, van Delden V, Furthmayr H, Kühn K A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981;120:203-211.
10. Bentsen KD, Horn T, Risteli J, Risteli L, Engström-Laurent A, Holslev-Petersen K, Lorenzen I, et al. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcoholic abuse: relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. Liver 1987;7:339-346.
11. Misaki M, Shima T, Yano Y, Sumita Y, Kano U, Murata T, Watanabe S, et al. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease. Clin Chem 1990;36:522-524.
12. Yamada S, Suou T, Kawasaki H, Yoshikawa N. Clinical significance of serum 7S collagen levels in various liver diseases. Clin Biochem 1992;25:467-470.
13. Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Serum type III procollagen peptide, type IV collagen 7S domain, central triplehelix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. HEPATOLOGY 1994;20:780-787.
14. Risteli J, Bächinger HP, Engel H, Furthmayr H, Timpl R. 7S-collagen: characterization of an unusual basement membrane structure. Eur J Biochem 1980;108:239-250.
15. Suou T, Yamada S, Kobayashi J, Hoshino U, Nishimuki E, Kawasaki H. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury. HEPATOLOGY 1993;18:809-815.
16. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. HEPATOLOGY 1994;19:1513-1520.
17. Yamada S, Aoto Y, Suou T, Hirayama C. Urinary hydroxyproline and hydroxylysine excretions in relation to hepatic hydroxyproline content in chronic liver disease. Clin Biochem 1989;22:389-393.
18. Yamada S, Kishimoto Y, Suou T, Kawasaki H, Horie Y. Heterogeneity of antigens related to 7S domain of type IV collagen in serum: application to patients with chronic liver disease. Clin Chim Acta 1992;212:73-78.
19. Savolainen E-R, Brocks D, Ala-Kokko L, Kivirikko KI. Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis. Biochem J 1988; 249:753-757.
20. 2-terminal propeptide of type III procollagen. HEPATOLOGY 1992;16:167-172.
21. Holt K, Bennett M, Chojkier M. Acetaldehyde stimulates collagen and noncollagen protein production by human fibroblasts. HEPATOLOGY 1984;4:843-848.
22. Casini A, Cunningham M, Rojkind M, Lieber CS. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. HEPATOLOGY 1991;13:758-765.
23. Niemelä O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology 1990;98:1612-1619.
24. Van Zanten RAA, van Leeuwen RE, Wilson JHP. Serum procollagen III N-terminal peptide and laminin PI fragment concentrations in alcoholic liver disease and primary biliary cirrhosis. Clin Chim Acta 1988;177:141-146.